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Abstract
Carbohydrate foods with high glycaemic index (GI) and load (GL) may negatively inﬂuence cancer risk. We studied the association of dietary
carbohydrates, GI, GL, intake of bread and pasta with risk of bladder cancer using data from an Italian case–control study. The study included 578 men
and women with histologically conﬁrmed bladder cancer and 608 controls admitted to the same hospitals as cases for acute, non-neoplastic
conditions. OR were estimated by logistic regression models after allowance for relevant confounding factors. OR of bladder cancer for the highest v.
the lowest quantile of intake were 1·52 (95% CI 0·85, 2·69) for available carbohydrates, 1·18 (95% CI 0·83, 1·67) for GI, 1·96 (95% CI 1·16, 3·31,
Ptrend<0·01) for GL, 1·58 (95% CI 1·09, 2·29, Ptrend=0·03) for pasta and 1·92 (95% CI 1·28, 2·86, Ptrend<0·01) for bread. OR for regular consumption of
legumes and whole-grain products were 0·78 (95% CI 0·60, 1·00) and 0·82 (95% CI 0·63, 1·08), respectively. No heterogeneity in risks emerged across
strata of sex. This case–control study showed that bladder cancer risk was directly associated with high dietary GL and with consumption of high
quantity of reﬁned carbohydrate foods, particularly bread. These associations were apparently stronger in subjects with low vegetable consumption.
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Worldwide, bladder cancer is the most frequent malignant
tumour of the urinary tract, with approximately 420 000 new
cases each year with 4-fold higher incidence rates in men than
in women(1). Although tobacco smoking is the major risk factor
for the development of bladder cancer accounting for up to
30–50% of cases(2), hyperglycaemia and hyperinsulinaemia
may play a role in initiation and progression.
Conditions characterised by long-term hyperinsulinaemia and
hyperglycaemia, such as the metabolic syndrome and type 2
diabetes, have been identiﬁed as risk factors for bladder cancer
incidence and mortality(3–7). In particular, a 10-year prospective
study including more than a million people found signi-
ﬁcantly higher mortality for bladder cancer in men with blood
glucose levels>6·9mmol/l, after adjusting for smoking, age and
alcohol drinking(4). Furthermore, poorly controlled glycaemia
(glycated Hb (HbA1c)>53 mmol/mol or>7·0%) in people with
diabetes increased the risk of recurrence of speciﬁc types of
bladder cancer compared with good glycaemic control
(HbA1c<53 mmol/mol or <7·0%)(8,9). These data suggest that
lifestyle factors promoting hyperglycaemia may play a role in
Abbreviations: GI, glycaemic index; GL, glycaemic load.
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bladder carcinogenesis. High glycaemic index (GI) and glycaemic
load (GL) foods raise blood glucose levels even in the absence of
diabetes, obesity and the metabolic syndrome. These foods
increase blood glucose levels to a greater extent than the equi-
valent amount of carbohydrates consumed from low-GI foods(10).
High-GI diets have been associated with greater risk of cancer(11,12)
including bladder cancer in North American populations(13,14).
To provide further information on the association between
dietary GI/GL and bladder cancer risk in a Mediterranean area,
we examined data from an Italian case–control study.
Methods
Study subjects
Between 2003 and 2014, we conducted a case–control study
on bladder cancer within an established Italian network of
collaborating centres, including Aviano and Milan in northern
Italy, and Naples and Catania in southern Italy(15).
Cases were 690 patients aged between 25 and 84 years
(median age: 67 years) with incident bladder cancer diagnosis,
admitted to major general hospitals in the catchment areas.
Nearly all cases (n 642, 93·0%) were conﬁrmed by histological
testing on tumour tissue specimen from biopsy or surgery and
three additional cases were conﬁrmed by cytology only.
Patients with self-reported history of diabetes mellitus (n 112)
may include diet modiﬁcation to control hyperglycaemia;
therefore, they were excluded from the present analysis,
leaving 578 cases (median age: 67 years).
Controls were 690 cancer-free patients aged between 27 and 84
years admitted to the same network of hospitals as cases for a
wide spectrum of acute conditions unrelated to tobacco smoking,
alcohol consumption or long-term diet modiﬁcation. Controls
were frequency-matched to cases by study centre, sex and age
(in 5-year groups). In all, twenty-ﬁve controls were excluded after
enrolment because of inappropriate admission diagnosis. After
excluding subjects with self-reported history of diabetes mellitus
(n 57), the total number of eligible controls was 608 (median age:
66 years). Of these, 28·3% were admitted for traumatic disorders,
22·5% for non-traumatic orthopaedic disorders, 38·7% for acute
surgical conditions and 10·5% for other various illnesses. Less
than 5% of cases and controls approached for interview during
their hospital stay refused to participate for personal reasons. The
power was adequate to detect 80% risk difference for variables
with a prevalence of at least 20%, at the usual 95% conﬁdence
limit. The present study was conducted according to the guide-
lines laid down in the Declaration of Helsinki and reported
according to the STROBE guidelines(16). All procedures involving
human subjects were approved by the Ethic Boards of each
study centre (Centro di Riferimento Oncologico (CRO)-Aviano,
University of Milan, National Cancer Institute Pascale). All study
subjects signed an informed consent before interview.
Data collection
Trained interviewers administered a structured questionnaire
to cases and controls during hospitalisation. It included
information on age, education and other socio-demographic
characteristics, anthropometric measures, selected lifestyle
habits (e.g. tobacco smoking), personal medical history and
family history of cancer. The presence of abdominal obesity
was deﬁned using the International Diabetes Federation cutoff
points (waist circumference ≥94 cm for men and ≥80 cm for
women). As the information on waist circumference could not
be obtained for technical reasons in 135 cases and 173 controls,
we considered the BMI≥ 30 kg/m2 as a proxy of abdominal
obesity in patients missing waist circumference.
An interviewer-administered FFQ was used to assess dietary
habits related to the 2 years preceding diagnosis/interview. This
included seventy-eight foods, food groups or recipes (i.e. the
most common ones in the Italian diet) structured into six
sections: (i) bread, cereals and ﬁrst courses; (ii) second courses
(i.e. meat, ﬁsh and other main dishes); (iii) side dishes
(i.e. vegetables); (iv) fruits; (v) desserts, sweets and soft drinks;
(vi) milk, hot beverages and sweeteners. An additional section
assessed the use of alcoholic beverages. Subjects were asked to
indicate the average weekly frequency of consumption for each
dietary item; intakes lower than once a week, but at least once a
month, were coded as 0·5/week. For fruit and vegetables sub-
ject to seasonal variation, consumption in season and the cor-
responding duration were elicited. The serving size was deﬁned
in ‘natural’ unit (e.g. 1 egg) or as an average serving in the
Italian diet (e.g. 50 g of salad, 150 g of tomatoes). The FFQ was
successfully tested for validity(17) and reproducibility(18). Total
energy and carbohydrate intake was computed using an Italian
food composition database(19).
Calculation of glycaemic index and glycaemic load
For each carbohydrate-containing food, we expressed GI as a
percentage of the glycaemic response elicited using white
bread as a standard food, using international GI tables(20). The
average daily GI of each subject was computed by summing
the products of the GI value of one serving of each food times
the average number of servings of that food consumed by the
subject per week divided by the weekly available carbo-
hydrate(20,21). In order to take into account Italian cooking habits
(e.g. pasta ‘al dente’), Italian sources were used for a few local
recipes(22). Food items for which a GI had not been determined
were assigned the GI of the closest comparable food (e.g.
tangerines were assigned the same GI of oranges). A score for the
daily average GL was computed by summing the products of the
GI value of one serving of each food times the average number of
servings of that food consumed by the subject per week.
Statistical analysis
OR for bladder cancer and the corresponding 95% CI were
estimated using unconditional logistic regression models
including terms for matching variables (study centre, sex,
quinquennia of age), and potential confounders including years
of education (<7, 7–11, ≥12 years), smoking habits (never,
former, current smokers of <20 and of ≥20 cigarettes/d),
alcohol drinking (<14, 14–20, ≥20 drinks/week), abdominal
obesity (yes/no) and total energy intake (kJ/d). GI, GL,
available carbohydrates, bread and pasta were entered in the
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models as quartiles based on the distribution of controls, using
the lowest quartile as the reference category. Given the low
consumption, legumes and whole-grain products were cate-
gorised as use v. abstinence. Tests for trend were based on the
likelihood-ratio test between the models with and without a
linear term for each variable of interest. Heterogeneity across
strata was tested by comparing the models with and without an
interaction term for such variable(23).
Results
Table 1 shows the distribution of cases and controls according
to socio-demographic characteristics, smoking habits, alcohol
drinking, abdominal obesity and total energy intake. Compared
with never smokers, heavy smokers (i.e.≥20 cigarettes/d) repor-
ted a 7-fold increase in bladder cancer risk (95% CI 4·58, 11·04)
with a signiﬁcant risk trend for number of cigarettes (P<0·01).
Patients with abdominal obesity showed a signiﬁcantly higher risk
of bladder cancer (OR 1·33; 95% CI 1·05, 1·69) as compared with
those without this condition. No signiﬁcant association emerged
for education, alcohol drinking and total energy intake.
Table 2 gives the OR for bladder cancer according to quartiles
of available carbohydrates, GI, GL and selected carbohydrate-
rich food groups. No signiﬁcant associations emerged for total
available carbohydrates (OR 1·52; 95% CI 0·85, 2·69) and for GI
(OR 1·18; 95% CI 0·83, 1·67), whereas a signiﬁcant direct
association was observed for GL, with an OR of 1·96 (95% CI
1·16, 3·31; P for trend< 0·01). Bread was directly associated with
bladder cancer risk with OR of 1·64 (95% CI 1·14, 2·35) and 1·92
(95% CI 1·28, 2·86) for the third and fourth quartiles, respec-
tively, compared with the lowest quartile (Pfor trend< 0·01).
Similarly, elevated pasta consumption was associated with
increased bladder cancer (OR 1·58; 95% CI 1·09, 2·29 in the
highest v. the lowest quartile of intake; Pfor trend= 0·03). The
association with pasta was signiﬁcant in men only (OR 1·81;
95% CI 1·20, 2·73; Pfor trend< 0·01), but no heterogeneity was
observed between men and women (P= 0·26). Although not
signiﬁcant, high regular use of whole-grain products and
legumes showed an inverse association with bladder cancer risk
(OR 0·82; 95% CI 0·63, 1·08 and OR 0·78; 95% CI 0·60, 1·00,
respectively), as compared with abstainers. No heterogeneity
emerged according to sex (Pfor heterogeneity≥ 0·05).
As vegetables and related seasoning, particularly olive oil,
may counteract the glycaemic response of food, the associa-
tions between bladder cancer risk and available carbohydrates,
GI, GL and intake of bread and pasta were further analysed in
separate strata of vegetable intake (Table 3). Although no
signiﬁcant heterogeneity emerged for all the considered food
items, results were suggestive that the effect for elevated GL
was stronger among people with vegetable consumption below
the median (i.e. 160 g/d) than among those above this level of
consumption (OR 2·41 and 1·74, respectively).
Discussion
Our study found that high dietary GL, an indicator of both
quality and quantity of carbohydrate foods, and high intakes of
bread and pasta were directly associated with bladder cancer
risk. Interestingly, these associations were less strong in people
with elevated vegetable consumption.
Two other studies, one conducted in the USA and one in
Canada, investigated the association of dietary GI and GL and
bladder cancer risk and found an increased risk with higher GI
but no association with GL(13,14). The apparent discrepancy in
results may be because of different dietary habits in different
countries. In the US study, the ﬁrst quantile of GL started at very
low values compared with the present Italian population, where
diets are very rich in total carbohydrates. The dietary GL is the
product of each food’s GI (derived from GI testing of foods in
human subjects) by the amount of total available carbohydrates
present in the same food (excluding unavailable carbohydrate
Table 1. Distribution of 578 bladder cancer cases and 608 controls
according to socio-demographic characteristics and selected variables
(Numbers and percentages, odds ratios and 95% confidence intervals)
Cases Controls
n % n % OR* 95% CI
Sex†
Man 491 85·0 513 84·4
Woman 87 15·0 95 15·6
Age (years)†
<55 78 13·5 105 17·3
55–59 53 9·2 68 11·2
60–64 91 15·7 107 17·6
65–69 137 23·7 129 21·2
70–74 125 21·6 113 18·6
≥75 94 16·3 86 14·1
Study centre†
Aviano 202 35·0 233 38·3
Milan 200 34·6 212 34·9
Naples 111 19·2 96 15·8
Catania 65 11·2 67 11·0
Education (years)‡
<7 233 40·4 242 39·8 1§
7–11 196 34·0 201 33·1 1·14 0·86, 1·52
≥12 148 25·6 165 27·1 1·05 0·77, 1·44
χ2 for trend Pfor trend=0·68
Smoking habits
Never 85 14·7 218 35·8 1§
Former 242 41·9 257 42·3 2·52 1·82, 3·49
Current (cigarettes/d)
<20 139 24·0 81 13·3 5·26 3·57, 7·74
≥20 112 19·4 52 8·6 7·11 4·58, 11·04
χ2 for trend Pfor trend<0·01
Alcohol drinking
(drinks/week)‡
<14 243 42·1 272 44·8 1§
14–20 185 32·1 197 32·5 1·05 0·80, 1·39
≥21 149 25·8 138 22·7 1·27 0·92, 1·76
χ2 for trend Pfor trend=0·16
Abdominal obesity
No 246 42·6 296 48·7 1§
Yes 332 57·4 312 51·3 1·33 1·05, 1·69
Total energy (kJ/d) P=0·02
<7840 141 24·4 152 25·0 1§
7840 to <9360 138 23·9 152 25·0 1·02 0·73, 1·41
9360 to <11351 163 28·2 152 25·0 1·24 0·89, 1·73
≥11351 136 23·5 152 25·0 1·07 0·75, 1·53
χ2 for trend Pfor trend=0·46
* Estimated by logistic regression model adjusted for sex, age and study centre.
† Matching variable.
‡ The sum does not add up to total because of missing values, one case for
education, one case and one control for alcohol.
§ Reference category.
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such as ﬁbre). A low-GL diet can be achieved by either
consuming low-GI foods or by consuming small amounts of
carbohydrate foods with any GI value or by consuming
both low-GI foods and small quantity of carbohydrate foods.
Considering that the Mediterranean–Italian diet is characterised
by frequent (e.g. daily) consumption of pasta (a medium–low
GI food), a high GL in Italy may be the result of very large
quantities of carbohydrates. High-carbohydrate diets, as typi-
cally seen in Italy, may need to include very low-GI foods
to show an impact on glycaemia. With the shift of the
Mediterranean diet towards more convenient and fast food
choices, lower-GI foods such as legumes, have become less
frequent on the plates of many Italians(24). It is possible that in
bladder cancer a high carbohydrate intake may confound any
potential association with GI. Diets with low GI (<69 on a bread
scale) and low GL are considered more beneﬁcial to overall
health, especially in environments characterised by sedentary
behaviour, excess energy intake and excess body weight(25).
Reducing the glycaemic impact of the overall diet with low-GI/
GL foods has been shown to decrease concentrations of fasting
Table 2. Distribution of 578 bladder cancer cases (Ca) and 608 controls (Co), according to available carbohydrates, glycaemic index,
glycaemic load, bread, pasta, legumes and whole-grain products
(Odds ratios and 95% confidence intervals)
Sex
Overall Men Women
Ca:Co Median intake OR* 95% CI OR* 95% CI OR* 95% CI
Available carbohydrates (g/d)
I (<223) 129:152 190 1† 1† 1†
II (223 to <270) 161:152 248 1·62 1·12, 2·35 1·57 1·04, 2·36 1·90 0·73, 4·95
III (270 to <325) 157:152 294 1·65 1·09, 2·51 1·50 0·95, 2·34 2·32 0·69, 7·83
IV (≥325) 131:152 379 1·52 0·85, 2·69 1·42 0·77, 2·63 2·07 0·32, 13·38
χ2 for trend P= 0·10 P= 0·26 P= 0·25
χ2 for heterogeneity: P= 0·86
Glycaemic index
I (<75) 136:152 72 1† 1† 1†
II (75 to <79) 135:152 77 1·07 0·75, 1·52 1·10 0·74, 1·62 1·06 0·45, 2·50
III (79 to <83) 140:152 81 1·03 0·73, 1·46 1·07 0·73, 1·57 0·84 0·34, 2·08
IV (≥83) 167:152 86 1·18 0·83, 1·67 1·18 0·80, 1·73 1·46 0·53, 4·02
χ2 for trend P= 0·44 P= 0·46 P= 0·70
χ2 for heterogeneity: P= 0·94
Glycaemic load
I (<169) 123:152 145 1† 1† 1†
II (169 to <210) 145:152 191 1·61 1·11, 2·34 1·54 1·02, 2·33 2·12 0·82, 5·48
III (210 to <257) 166:152 229 2·03 1·36, 3·04 1·94 1·25, 3·00 2·66 0·86, 8·21
IV (≥257) 144:152 302 1·96 1·16, 3·31 1·85 1·05, 3·26 2·82 0·56, 14·19
χ2 for trend P<0·01 P= 0·01 P= 0·14
χ2 for heterogeneity: P= 0·83
Bread (g/d)‡
I (<54) 112:153 43 1† 1† 1†
II (54 to <102) 132:143 89 1·44 0·99, 2·08 1·51 1·00, 2·29 1·26 0·53, 2·95
III (102 to <154) 168:167 118 1·64 1·14, 2·35 1·65 1·11, 2·48 1·68 0·70, 4·03
IV (≥154) 166:145 206 1·92 1·28, 2·86 1·79 1·16, 2·77 4·31 1·08, 17·21
χ2 for trend P<0·01 P= 0·01 P= 0·05
χ2 for heterogeneity: P= 0·67
Pasta (g/d)§||
I (<43) 158:167 34 1† 1† 1†
II (43 to <57) 116:134 49 1·19 0·82, 1·73 1·32 0·88, 2·00 0·77 0·30, 2·01
III (57 to <70) 135:160 63 1·12 0·78, 1·61 1·29 0·86, 1·93 0·62 0·25, 1·58
IV (≥70) 169:147 83 1·58 1·09, 2·29 1·81 1·20, 2·73 1·08 0·40, 2·90
χ2 for trend P= 0·03 P< 0·01 P= 0·91
χ2 for heterogeneity: P= 0·26
Legumes (g/d)||
Abstainers 374:353 0 1† 1† 1†
Regular users 204:255 14 0·78 0·60, 1·00 0·79 0·60, 1·05 0·67 0·33, 1·37
χ2 for heterogeneity: P= 0·68
Whole-grain products (g/d)
Abstainers 410:393 0 1† 1† 1†
Regular users 168:215 43 0·82 0·63, 1·08 0·76 0·56, 1·03 1·24 0·63, 2·45
χ2 for heterogeneity: P= 0·20
* Estimated by logistic regression model, adjusted for sex, age, study centre, education, smoking habits, alcohol drinking, abdominal obesity and
total energy.
† Reference category.
‡ Includes also crackers and bread sticks.
§ Includes also rice.
|| Uncooked.
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blood glucose, glycosylated proteins, insulin and inﬂammatory
markers, and to reduce the risk of developing type 2 diabetes
and some cancers(14,25). Fasting hyperglycaemia (>7·0mmol/l)
has been found to signiﬁcantly increase bladder cancer risk in
an Asian study including 1·3 million people aged 30–95 years(4).
Insulin can activate epidermal growth factors and protein
kinases and in in vitro studies insulin increased bladder cancer
cell proliferation in a time- and dose-dependent manner(26,27).
The diabetic medication metformin, which helps to control both
glycaemia and insulin resistance, has been shown to reduce
growth of malignant cell types including bladder cancer
cells(28,29). It is also possible that diets promoting large increases
in blood glucose may promote urinary tract infections and
hence increase bladder cancer risk(30).
Two main staple carbohydrate foods of the Italian Medi-
terranean diet are bread (high GI) and pasta (medium–low GI),
representing 24 and 16% of total carbohydrate intake,
respectively(31). Generally, the associations with cancer risk
have been stronger for bread than for pasta(32,33) and with a
difference between sexes. In a previous Italian study investi-
gating the association of pasta or bread and colorectal or breast
cancer, the associations with bread were stronger in women
than in men(32). In the current study, bread, pasta and GL were
directly and signiﬁcantly associated with bladder cancer parti-
cularly in men. Men are generally affected by bladder cancer
three to four times more often than women(34,35), and several
in vitro and animal studies suggest a potential involvement of
sex steroid hormonal pathways(36). Indeed, recent evidence
suggests that androgen and androgen receptor may contribute
to bladder carcinogenesis both through hormonal pathways
and by other mechanisms such as reduced expression of
detoxifying enzymes in the bladder(37,38). It is possible that
diets that increase blood glucose the most may favour higher
testosterone bioavailability by reducing its binding protein(39).
Table 3. Distribution of 578 bladder cancer cases and 608 controls, according to quartiles of available carbohydrates, glycaemic
index, glycaemic load, consumption of bread and pasta, in strata of vegetable intake
(Odds ratios and 95% confidence intervals)
Vegetable intake (g/d)
<160 ≥160
Median intake OR* 95% CI OR* 95% CI
Available carbohydrates (g/d)
I (<223) 190 1† 1†
II (223 to <270) 248 1·35 0·83, 2·18 2·14 1·10, 4·17
III (270 to <325) 294 1·86 1·02, 3·40 1·64 0·84, 3·20
IV (≥325) 379 1·67 0·68, 4·06 1·50 0·64, 3·52
χ2 for trend P= 0·09 P= 0·61
χ2 for heterogeneity: P= 0·70
Glycaemic index
I (<75) 72 1† 1†
II (75 to <79) 77 1·36 0·83, 2·24 0·91 0·54, 1·53
III (79 to <83) 81 1·41 0·86, 2·32 0·80 0·47, 1·34
IV (≥83) 86 1·35 0·82, 2·22 0·93 0·54, 1·60
χ2 for trend P= 0·26 P= 0·65
χ2 for heterogeneity: P= 0·18
Glycaemic load
I (<169) 145 1† 1†
II (169 to <210) 191 1·43 0·88, 2·32 2·01 1·04, 3·88
III (210 to <257) 229 2·24 1·26, 3·99 1·93 1·01, 3·69
IV (≥257) 302 2·41 1·06, 5·47 1·74 0·80, 3·77
χ2 for trend P< 0·01 P= 0·25
χ2 for heterogeneity: P= 0·77
Bread (g/d)‡
I (<54) 43 1† 1†
II (54 to <102) 89 1·37 0·85, 2·21 1·49 0·81, 2·75
III (102 to <154) 118 1·71 1·05, 2·77 1·44 0·80, 2·58
IV (≥154) 206 1·83 1·02, 3·31 1·85 1·01, 3·39
χ2 for trend P= 0·02 P= 0·07
χ2 for heterogeneity: P= 0·96
Pasta (g/d)§||
I (<43) 34 1† 1†
II (43 to <57) 49 1·06 0·65, 1·72 1·40 0·75, 2·60
III (57 to <70) 63 1·04 0·65, 1·67 1·19 0·65, 2·19
IV (≥70) 83 1·73 1·03, 2·92 1·55 0·86, 2·79
χ2 for trend P=0·07 P= 0·20
χ2 for heterogeneity: P= 0·86
* Estimated by logistic regression model, adjusted for sex, age, study centre, education, smoking habits, alcohol drinking, abdominal obesity and total energy.
† Reference category.
‡ Includes also crackers and bread sticks.
§ Includes also rice
|| Uncooked.
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Furthermore, the results of our study suggest that the associa-
tions between bladder cancer risk and GL may be stronger among
people with a lower vegetable intake (<160g/d) than in those
with higher intakes (>160g/d), possibly because of components
present in vegetables (e.g. ﬁbre and antioxidants) or consumed
with vegetables (e.g. olive oil) that may modify the glycaemic
response by various mechanisms (e.g. slowing carbohydrate
absorption or reducing glucose toxicity to the beta cells)(40,41).
As for most case–control studies, information and selection
biases were potential limitations of this study. Information
bias, however, was minimised by the administration of the
questionnaire to both cases and controls by the same trained
interviewers, under similar conditions in a hospital setting.
Differential recall in cases and controls in our study may be
unlikely as the dietary hypothesis of GI and GL in bladder
cancer risk was not known during the study and the ques-
tionnaire was satisfactorily reproducible(42). However, as the
information was collected after diagnosis, it is possible that early
symptoms of the disease may have caused changes in the diet.
To avoid these potential sources of bias, any relevant dietary
change in the 2 years preceding interview were recorded and
we excluded from the control group all subjects with diagnoses
that might have implicated long-term dietary modiﬁcations (e.g.
diabetes). Furthermore, a possible limiting factor in our analyses
was for the calculation of abdominal obesity where waist
circumference was missing in approximately 25% of cases
and controls and BMI≥ 30 kg/m2 was used as a proxy. BMI≥
30 kg/m2 is considered a good proxy of abdominal obesity,
and analyses conducted excluding patients with missing waist
circumference did not show appreciable variation in risk mag-
nitude. In addition, GI and GL values may have some variability
according to speciﬁc foods and cooking methods. In particular,
although pasta and rice have different glycaemic responses,
they were assessed together in our FFQ. However, this infor-
mation bias is unlikely to have an impact on risk estimates,
as rice accounts for<20% in this food group of this study
population(43). The almost complete participation of identiﬁed
cases and controls, and the use of a validated and reproducible
questionnaire, contributed to strengthen our ﬁndings.
Generalisability of our study results has the limitations dis-
cussed above, typical of a hospital case–control study.
In conclusion, this study showed that bladder cancer risk is
directly associated with high dietary GL and with consumption
of high quantity of reﬁned carbohydrates. These associations
were stronger in subjects reporting low vegetable consumption.
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